Biosimilars Get Bespoke Service: EMA To Pilot Tailored Scientific Advice

Quality data will be focus of ‘extra advice’ offered by European Medicines Agency’s pilot, which will suggest directions for sponsors’ next steps but stop short of formal data evaluation.